Esperion Therapeutics

Esperion Therapeutics

Esperion Therapeutics

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Founded
2008
Raised
$245.7M
Follow us
Alexa global traffic share
Twitter followers
24 Mar 2015
$189,900,000
Post-IPO equity
25 Apr 2013
$33,000,000
Venture capital
01 May 2008
$22,750,000
Venture capital (Series A)